Events

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - June 2024

The Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) was established under Regulation 2022/123 on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices.

Online
European Medicines Agency, Amsterdam, the Netherlands
Fecha de inicio: 26 Junio 2024, 10:00 (CEST)
Fecha final: 26 Junio 2024, 12:00 (CEST)
EventHumanVeterinaryMedicine shortages
Quarterly system demo - Q2 2024
Online
European Medicines Agency, Amsterdam, the Netherlands
Live broadcast
Fecha de inicio: 26 Junio 2024, 09:00 (CEST)
Fecha final: 26 Junio 2024, 13:30 (CEST)
EventCorporate
Quarterly System Demo – Q2 2024 (Copy)
Online
European Medicines Agency, Amsterdam, the Netherlands
Live broadcast
Fecha de inicio: 26 Junio 2024, 09:00 (CEST)
Fecha final: 26 Junio 2024, 13:30 (CEST)
EventCorporate
Webinar for industry and contract research organisations (CROs) on revised Environmental Risk Assessment (ERA) guideline for human medicinal products

The ERA-DG together with additional technical experts from the EU network is hosting a stakeholder webinar for industry and contract research organisations (CROs) on the revised ERA guideline for human medicinal products.

Online
European Medicines Agency, Amsterdam, the Netherlands
Fecha de inicio: 26 Junio 2024
Fecha final: 26 Junio 2024
EventHuman
Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system

EudraVigilance is the EU's system for managing and analysing information on adverse reactions to medicines which have been authorised or are being studied in clinical trials in the European Economic Area (EEA) and supports the reporting and analysis of suspected adverse reactions originating from clinical trials and the post-authorisation phase of...

Online
Fecha de inicio: 24 Junio 2024
Fecha final: 28 Junio 2024
EventHumanClinical trials